TrialNature medicine2022

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.

Boris Julg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.